The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
Status:
Completed
Trial end date:
2019-01-17
Target enrollment:
Participant gender:
Summary
This study is examining the effects of growth hormone releasing hormone (GHRH) on mild
cognitive impairment (MCI). GHRH will be given at a dose of 1mg/day for 10 weeks to subjects
with MCI as well as healthy controls.